Company Quick10K Filing
Belmond
10-K 2018-12-31 Filed 2019-02-28
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-25
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-30 Filed 2013-11-01
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-05-03
10-K 2012-12-31 Filed 2013-02-26
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-02-25
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-02-26
8-K 2019-04-17
8-K 2019-02-27
8-K 2019-02-14
8-K 2019-01-08
8-K 2018-12-13
8-K 2018-11-06
8-K 2018-10-11
8-K 2018-08-24
8-K 2018-08-08
8-K 2018-08-08
8-K 2018-07-06
8-K 2018-06-01
8-K 2018-05-08
8-K 2018-04-20
8-K 2018-04-03
8-K 2018-02-26
8-K 2018-02-08

Belmond Financials

BEL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
1st Franklin Financial (FFC) 4 -0.6 7% 905 645 0 0 62 80 -46
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200 7.9 1% 6,691 5,858 0 0 70 136 1,073
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 2 0 0 -2 -2 0
21Vianet Group (VNET) 6,005 0% 11,151 5,788 0 0 0 0 3,344
22nd Century (XXII) 302 1% -14.1 -36% 62 7 26 0 -22 -21 302
1Life Healthcare (ONEM)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash1131321501171131199067721029379114153123134133159135110157175136121145178153131114205180142169150112
Accounts Receivable6160514351464551514737404344353641393032353327293132262937433451615438
Inventory4245444650474446444545434545454544413128282626272727242425242322222221
PP&E1,2421,2861,2691,2841,6071,5071,4631,5181,4051,4451,4731,4301,4391,4771,4521,4001,4261,5741,5071,4341,4761,4361,4221,4651,4651,4811,4441,4761,5731,5881,5861,6811,6621,6761,702
Assets2,1232,1712,1382,1702,1692,0061,9311,9481,8991,9141,8921,8241,8601,9191,8801,8201,8331,7801,6681,5851,6161,5901,5091,5311,5461,5881,5241,5281,6131,7181,6541,7051,7271,7221,676
Accounts Payable2929252240312927292825232723242126252517232016131517161319161616182623
Long-Term Debt535241511522612572544537525517522424438351473546541621612591596595578584595596586587597698701746778740754
Liabilities1,1551,1931,0651,0891,0801,0169789909719689549479719989699799759629068849039088518608758908378449159959551,0071,0591,0471,036
Stockholders' Equity9659761,0711,0791,087988950955926943936875886918908840856817761701712681658670670698686684697723699698668674640
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Revenue169182128104177184124109162160121104172187131103176184124991611681239715418411495166183490172193
Cost of Revenue
Gross Profit
R&D
SG&A50494849606057535551545562585751585754485554494750534852745954566968
Tax6710-5954867106412941215-151611-151420-9422192714
Net Income-1-22-26-155-50-28-151218-21-471716-18-21615-2-91590-18237-18-58-30-15-213
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash Operating39-21-13128-13-72646-19-63852-16-113043-10-13943-12-22248-6-92152-13-73365
Cash Investing-6-12-239-11-9-2456-2-22-14-627-27-11-10-1724-10-14-11-14-13-15-12-84-15-9-76-45-43
Cash Financing-1351-10-45-17-20-74-14-2-419-1-6-4-50-2-1-19-12-11-316-1-1-24449-13844-39